These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 7877257

  • 1. Analysis of the neurofibromatosis 2 gene in human breast and hepatocellular carcinomas.
    Kanai Y, Tsuda H, Oda T, Sakamoto M, Hirohashi S.
    Jpn J Clin Oncol; 1995 Feb; 25(1):1-4. PubMed ID: 7877257
    [Abstract] [Full Text] [Related]

  • 2. Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas.
    Ueki K, Wen-Bin C, Narita Y, Asai A, Kirino T.
    Cancer Res; 1999 Dec 01; 59(23):5995-8. PubMed ID: 10606247
    [Abstract] [Full Text] [Related]

  • 3. p27/Kip1 mutation found in breast cancer.
    Spirin KS, Simpson JF, Takeuchi S, Kawamata N, Miller CW, Koeffler HP.
    Cancer Res; 1996 May 15; 56(10):2400-4. PubMed ID: 8625318
    [Abstract] [Full Text] [Related]

  • 4. [Neurofibromatosis type 2 (NF2)].
    Araki N, Takeshima H, Saya H.
    Gan To Kagaku Ryoho; 1997 Sep 15; 24(11):1427-31. PubMed ID: 9309136
    [Abstract] [Full Text] [Related]

  • 5. The neurofibromatosis type 2 gene product, schwannomin, suppresses growth of NIH 3T3 cells.
    Lutchman M, Rouleau GA.
    Cancer Res; 1995 Jun 01; 55(11):2270-4. PubMed ID: 7757975
    [Abstract] [Full Text] [Related]

  • 6. Frequent mutations of NF2 and allelic loss from chromosome band 22q12 in malignant mesothelioma: evidence for a two-hit mechanism of NF2 inactivation.
    Cheng JQ, Lee WC, Klein MA, Cheng GZ, Jhanwar SC, Testa JR.
    Genes Chromosomes Cancer; 1999 Mar 01; 24(3):238-42. PubMed ID: 10451704
    [Abstract] [Full Text] [Related]

  • 7. PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas.
    Lee JW, Soung YH, Kim SY, Lee HW, Park WS, Nam SW, Kim SH, Lee JY, Yoo NJ, Lee SH.
    Oncogene; 2005 Feb 17; 24(8):1477-80. PubMed ID: 15608678
    [Abstract] [Full Text] [Related]

  • 8. Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types.
    Bianchi AB, Hara T, Ramesh V, Gao J, Klein-Szanto AJ, Morin F, Menon AG, Trofatter JA, Gusella JF, Seizinger BR.
    Nat Genet; 1994 Feb 17; 6(2):185-92. PubMed ID: 8162073
    [Abstract] [Full Text] [Related]

  • 9. Mutational analysis of tumour suppressor gene NF2 in common solid cancers and acute leukaemias.
    Yoo NJ, Park SW, Lee SH.
    Pathology; 2012 Jan 17; 44(1):29-32. PubMed ID: 22081132
    [Abstract] [Full Text] [Related]

  • 10. p300 gene alterations in colorectal and gastric carcinomas.
    Muraoka M, Konishi M, Kikuchi-Yanoshita R, Tanaka K, Shitara N, Chong JM, Iwama T, Miyaki M.
    Oncogene; 1996 Apr 04; 12(7):1565-9. PubMed ID: 8622873
    [Abstract] [Full Text] [Related]

  • 11. Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas.
    Rubio MP, Correa KM, Ramesh V, MacCollin MM, Jacoby LB, von Deimling A, Gusella JF, Louis DN.
    Cancer Res; 1994 Jan 01; 54(1):45-7. PubMed ID: 8261460
    [Abstract] [Full Text] [Related]

  • 12. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands.
    Ahmadian M, Wistuba II, Fong KM, Behrens C, Kodagoda DR, Saboorian MH, Shay J, Tomlinson GE, Blum J, Minna JD, Gazdar AF.
    Cancer Res; 1997 Sep 01; 57(17):3664-8. PubMed ID: 9288768
    [Abstract] [Full Text] [Related]

  • 13. Frequency and distribution of NF2 mutations in schwannomas.
    Jacoby LB, MacCollin M, Barone R, Ramesh V, Gusella JF.
    Genes Chromosomes Cancer; 1996 Sep 01; 17(1):45-55. PubMed ID: 8889506
    [Abstract] [Full Text] [Related]

  • 14. [Mutation analysis of the tumor suppressor gene PTEN/MMAC1/TEP1 in human hepatocellular carcinoma].
    Zhang LN, Zha XL, Yu Q, He JY.
    Shi Yan Sheng Wu Xue Bao; 2000 Sep 01; 33(3):223-7. PubMed ID: 12549040
    [Abstract] [Full Text] [Related]

  • 15. Expression of neurofibromatosis 2 transcript and gene product during mouse fetal development.
    Huynh DP, Tran TM, Nechiporuk T, Pulst SM.
    Cell Growth Differ; 1996 Nov 01; 7(11):1551-61. PubMed ID: 8930405
    [Abstract] [Full Text] [Related]

  • 16. Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.
    Kley N, Whaley J, Seizinger BR.
    Glia; 1995 Nov 01; 15(3):297-307. PubMed ID: 8586465
    [Abstract] [Full Text] [Related]

  • 17. The neurofibromatosis 2 (NF2) tumour suppressor gene: implications beyond the hereditary tumour syndrome?
    Kley N, Seizinger BR.
    Cancer Surv; 1995 Nov 01; 25():207-18. PubMed ID: 8718520
    [Abstract] [Full Text] [Related]

  • 18. Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer.
    Sekido Y, Pass HI, Bader S, Mew DJ, Christman MF, Gazdar AF, Minna JD.
    Cancer Res; 1995 Mar 15; 55(6):1227-31. PubMed ID: 7882313
    [Abstract] [Full Text] [Related]

  • 19. Mutational analysis of the nf2 tumour suppressor gene in three subtypes of primary human malignant mesotheliomas.
    Schipper H, Papp T, Johnen G, Pemsel H, Bastrop R, Müller KM, Wiethege T, Jaworska M, Krismann M, Schiffmann D, Rahman Q.
    Int J Oncol; 2003 May 15; 22(5):1009-17. PubMed ID: 12684666
    [Abstract] [Full Text] [Related]

  • 20. Frequent loss of heterozygosity on chromosome 22 in hepatocellular carcinoma.
    Takahashi K, Kudo J, Ishibashi H, Hirata Y, Niho Y.
    Hepatology; 1993 May 15; 17(5):794-9. PubMed ID: 8387946
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.